scPharmaceuticals Inc (SCPH) Performance and Fundamentals Dashboard tells a completely different story

With 0.99 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.42 million shares. The 52-week range on SCPH shows that it touched its highest point at $6.20 and its lowest point at $2.91 during that stretch. It currently has a 1-year price target of $17.50. Beta for the stock currently stands at 0.32.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SCPH was down-trending over the past week, with a drop of -9.97%, but this was down by -11.62% over a month. Three-month performance dropped to -16.47% while six-month performance fell -44.32%. The stock lost -51.02% in the past year, while it has lost -18.36% so far this year. A look at the trailing 12-month EPS for SCPH yields -1.91 with Next year EPS estimates of -0.95. For the next quarter, that number is -0.38. This implies an EPS growth rate of -27.13% for this year and 47.27% for next year.

Float and Shares Shorts:

At present, 50.04 million SCPH shares are outstanding with a float of 34.09 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for SCPH since 1 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$1.72877 being high and -$1.92935 being low. For SCPH, this leads to a yearly average estimate of -$1.80518. Based on analyst estimates, the high estimate for the next quarter is -$0.31 and the low estimate is -$0.41. The average estimate for the next quarter is thus -$0.36.